Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Change in Receivables (2024 - 2025)

Abpro Holdings' (ABPO) quarterly Change in Receivables came in at $11000.0 in Q2 2025, down 65.62% YoY from $32000.0 in Q2 2024, and up 37.5% on a QoQ basis from $8000.0 in Q1 2025.

Abpro Holdings (ABPO) Change in Receivables (2024 - 2025) Analysis & Trends

Abpro Holdings (ABPO) has 2 years of Change in Receivables data on file, last reported at $11000.0 in Q2 2025.

  • Quarterly Change in Receivables fell 65.62% year-over-year to $11000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $83000.0 (changed N/A YoY) and the FY2024 annual result came in at $95000.0, up 104.89% from the prior year.
  • Change in Receivables advanced to $11000.0 in Q2 2025, from $8000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $152000.0 in Q3 2024 to a low of -$88000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -53.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 117.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 31.60 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 94.29 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 37.16 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Abpro Holdings 1.14 Mn 1.14 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 11,000.00
Jun 30, 2025 11,000.00
Mar 31, 2025 8,000.00
Mar 31, 2025 8,000.00
Dec 31, 2024 -88,000.00
Dec 31, 2024 -88,000.00
Sep 30, 2024 152,000.00
Sep 30, 2024 152,000.00
Jun 30, 2024 32,000.00
Jun 30, 2024 32,000.00
Mar 31, 2024 -1,000.00
Mar 31, 2024 -1,000.00